Work

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw240

Authors: M. Simonelli, P. Zucali, A. Santoro, M.B. Thomas, F.G. de Braud, H. Borghaei, J. Berlin, C.S. Denlinger, C. Noberasco, L. Rimassa, T.-Y. Kim, P.A. English, A. Abbattista, C. Gallo Stampino, M. Carpentieri, J.A. Williams

Institutions: Fondazione Humanitas per la Ricerca, Medical University of South Carolina, European Institute of Oncology, Fox Chase Cancer Center, Vanderbilt University, Pfizer (United States)

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Pfizer

OpenAlex ID: W2462071496

FWCI: 3.855

Cites: 24

Cited by: 41

Related to: 10